Nexentis Technologies Inc. (NXTS)
NASDAQ: NXTS · Real-Time Price · USD
2.210
+0.200 (9.95%)
At close: Nov 13, 2026, 4:00 PM EST
2.270
+0.060 (2.71%)
Pre-market: Nov 16, 2026, 7:23 AM EST
Nexentis Technologies Employees
As of December 31, 2025, Nexentis Technologies had 9 total employees, including 7 full-time and 2 part-time employees. The number of employees increased by 4 or 80.00% compared to the previous year. That makes Nexentis Technologies the 40,615th largest employer in the world and 6,100th in the United States.
Employees
9
Change (1Y)
4
Growth (1Y)
80.00%
Revenue / Employee
n/a
Profits / Employee
-$1,780,778
Market Cap
642.37K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | 4 | 80.00% | 7 | 2 |
| Dec 31, 2024 | 5 | 2 | 66.67% | 3 | 2 |
| Dec 31, 2023 | 3 | -5 | -62.50% | 2 | 1 |
| Dec 31, 2022 | 8 | -2 | -20.00% | 6 | 2 |
| Dec 31, 2021 | 10 | 4 | 66.67% | 9 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Corteva | 21,500 |
| The Mosaic Company | 13,249 |
| ICL Group | 12,000 |
| FMC Corporation | 5,500 |
| The Scotts Miracle-Gro Company | 5,200 |
| CF Industries Holdings | 2,900 |
| American Vanguard | 739 |
| Bioceres Crop Solutions | 562 |
NXTS News
- 9 days ago - Nexentis Technologies Inc trading halted, news pending - TheFly
- 10 days ago - Nexentis Technologies announces one-for-five reverse stock split - TheFly
- 10 days ago - Nexentis Announces Reverse Stock Split - GlobeNewsWire
- 18 days ago - Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz - GlobeNewsWire
- 21 days ago - Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage - GlobeNewsWire
- 5 weeks ago - Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud - GlobeNewsWire
- 7 weeks ago - Nexentis Technologies appoints Major to Scientific Advisory Board - TheFly
- 7 weeks ago - Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board - GlobeNewsWire